Bacterial News and Research

RSS

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Da Volterra, a leading biopharmaceutical company in the field of bacterial resistance, announces today very promising new results about DAV132 in the prevention of the side effects of antibiotics and the occurrence of severe Clostridium difficile infections.

13 May 2014

Navy asks Rice synthetic biologist to tweak gut bacteria for mood, weight control

The motto "no guts, no glory" may need rewriting if Rice University synthetic biologist Jeff Tabor succeeds in his quest to help the Navy create an edible probiotic bacterium that can help protect sailors and marines from obesity and depression.

13 May 2014

New breakthrough offers easier way of detecting pathogenic bacteria outside clinical setting

The breakthrough, published in the journal Nature Materials, could offer an easier way of detecting pathogenic bacteria outside of a clinical setting and could be particularly important for the developing world, where access to more sophisticated laboratory techniques is often limited.

13 May 2014

Max Planck researchers elucidate important mechanism of protein folding

Proteins are the workhorses of the cell and thus responsible for almost all biological functions including metabolism, signal transmission or the determination of the cell's shape. However, before they can fulfill their various tasks, the chain-like molecules must first adopt an intricate three-dimensional conformation.

13 May 2014

S. pneumoniae interacts with other nasopharyngeal bacteria

Streptococcus pneumoniae bacteria are able to detect and respond to other bacterial species in the same host niche, researchers report in Open Biology.

12 May 2014

Study encourages schools to be more aware of hand-washing

Dr. Michael Gabriel of GPM Pediatrics, a New York based Pediatric Center, comments on an article that says children are more likely to wash their hands when someone is around or watching. This new study could prove to be useful in reducing the amount of infectious diseases contracted by children.

8 May 2014

FDA-cleared BD MAX Enteric Bacterial Panel now available to detect bacterial pathogens

BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the FDA-cleared BD MAX Enteric Bacterial Panel for use on the BD MAX System.

From BD (Becton, Dickinson and Company) 7 May 2014

Breastfeeding promotes growth of beneficial lactic acid bacteria in baby's gut flora

The nutritional factor that has the greatest impact on the development of a child's gut flora is whether the child is breastfed, according to a new study by the National Food Institute, Technical University of Denmark, and the University of Copenhagen.

7 May 2014

Researchers discover genetic risk factor for premature birth

Researchers at the University of California, San Diego School of Medicine have discovered a genetic risk factor for premature birth.

7 May 2014

Inflammatory pneumococcal response differs by age

The composition of inflammatory lung infiltrate in people with pneumonia caused by Streptococcus pneumoniae differs by age, an in-situ study reveals.

6 May 2014

New study explores how bacterial pathogen Yersinia tries to outsmart immune cell responses

A new study led by scientists at the University of Pennsylvania School of Veterinary Medicine has painted a clearer picture of the delicate arms race between the human immune system and a pathogen that seeks to infect and kill human cells.

6 May 2014

Scientists identify benign bacterium that blocks Salmonella from colonizing raw tomatoes

Scientists from the U.S. Food and Drug Administration (FDA) have identified a benign bacterium that shows promise in blocking Salmonella from colonizing raw tomatoes.

6 May 2014

Rates of infant immunization with pertussis-containing vaccine do not increase with epidemic

Conventional wisdom holds that when the risk of catching a disease is high, people are more likely to get vaccinated to protect themselves.

6 May 2014

NIH award reflects urgency of overcoming infections that resist drug treatment

The National Institute of Allergy and Infectious Diseases of the National Institutes of Health has selected infectious disease expert David Perlin, executive director of the Public Health Research Institute at Rutgers New Jersey Medical School, to lead a major research effort aimed at developing new forms of antibiotics to regain the upper hand over deadly bacteria that have become resistant to current treatments.

26 Apr 2014

Bile acids could be a new target for treating obesity and diabetes, say researchers

Bariatric surgery has positive effects not only on weight loss but also on diabetes and heart disease. Researchers at the Sahlgrenska Academy and University of Cincinnati have shown that the health benefits are not caused by a reduction in the stomach size but by increased levels of bile acids in the blood.

23 Apr 2014

Bayer's Ciprofloxacin DPI receives FDA orphan drug designation for NCFB treatment

Bayer HealthCare today announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for its investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis (NCFB).

23 Apr 2014

Pediatric viral respiratory tract infection often complicated by bacterial sinusitis

Nearly 1 in 10 cases of viral upper respiratory tract infections in infants and young children is complicated by acute bacterial sinusitis, often in conjunction with acute otitis media, a longitudinal cohort study has found.

22 Apr 2014

Pediatrician reviews co-pathogenesis of influenza viruses with bacteria in lung

Le Bonheur Children's Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited to submit a review in the April issue of Nature Reviews Microbiology, one of the world's foremost scientific publications.

22 Apr 2014

Researchers study evolution of harmful organisms from 1 bacterial family

For the first time, researchers have studied the Black Death bacterium's entire family tree to fully understand how some of the family members evolve to become harmful.

22 Apr 2014

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).

21 Apr 2014

Bacterial News and Research

Da Volterra presents promising results of DAV-132 compound for prevention of severe C. diff infections

Navy asks Rice synthetic biologist to tweak gut bacteria for mood, weight control

New breakthrough offers easier way of detecting pathogenic bacteria outside clinical setting

Max Planck researchers elucidate important mechanism of protein folding

S. pneumoniae interacts with other nasopharyngeal bacteria

Study encourages schools to be more aware of hand-washing

FDA-cleared BD MAX Enteric Bacterial Panel now available to detect bacterial pathogens

Breastfeeding promotes growth of beneficial lactic acid bacteria in baby's gut flora

Researchers discover genetic risk factor for premature birth

Inflammatory pneumococcal response differs by age

New study explores how bacterial pathogen Yersinia tries to outsmart immune cell responses

Scientists identify benign bacterium that blocks Salmonella from colonizing raw tomatoes

Rates of infant immunization with pertussis-containing vaccine do not increase with epidemic

NIH award reflects urgency of overcoming infections that resist drug treatment

Bile acids could be a new target for treating obesity and diabetes, say researchers

Bayer's Ciprofloxacin DPI receives FDA orphan drug designation for NCFB treatment

Pediatric viral respiratory tract infection often complicated by bacterial sinusitis

Pediatrician reviews co-pathogenesis of influenza viruses with bacteria in lung

Researchers study evolution of harmful organisms from 1 bacterial family

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News